SAN DIEGO--(BUSINESS WIRE)--Aug. 7, 2008--Illumina, Inc. (NASDAQ:ILMN) today announced the pricing of its public offering of 3,500,000 shares of common stock at a public offering price of $87.50 per share, resulting in estimated net proceeds to Illumina of approximately $297.9 million. The company has granted the underwriter an option to purchase up to 525,000 additional shares of common stock from the company. The underwriter may exercise this option within a period of 30 days after the date of the prospectus supplement relating to the offering.

Goldman, Sachs & Co. is acting as the sole manager of the offering.

This communication is not an offer to sell or the solicitation of an offer to buy these securities, nor will there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale is not permitted. Copies of the prospectus supplement and accompanying prospectus may be obtained from the Prospectus Department of Goldman, Sachs & Co., 100 Burma Road, Jersey City, NJ 07305. Phone: 212-902-1171, Facsimile: 212-902-9316, and e-mail at prospectus-ny@ny.email.gs.com.

About Illumina

Illumina develops and markets next-generation tools for the large-scale analysis of genetic variation and function.

CONTACT: Illumina, Inc.
Investors:
Christian Henry, Sr. Vice President & CFO
858-202-4508
chenry@illumina.com
or
Media:
Maurissa Bornstein, Public Relations Manager
858-332-4055
mbornstein@illumina.com
or
Peter J. Fromen, Sr. Director, Investor Relations
858-202-4507
pfromen@illumina.com

SOURCE: Illumina, Inc.